Evidence-based Screening Strategies for Celiac Disease

Sponsor
Katri Kaukinen
Study ID
NCT03136731
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
6 Months - 100 Years
Healthy Volunteers
Accepted

Interventions

  • Celiac disease antibody screening — DIAGNOSTIC_TEST
    Observational parameters

Study Details

Main aim: To find evidence-based screening strategies for celiac disease in high risk groups and to find new biomarkers or biomarker combinations for celiac disease diagnostics and follow-up.

Key Dates

First listed
May 2, 2017
Start date
Nov 29, 2017
Status verified
Jan 2023
Primary completion
Dec 31, 2023
Completion
Dec 31, 2032

Study Design

Enrollment
3,517 participants (estimated)

Arms

  • Arm: Healthy family members of celiac disease
    Celiac disease screening, no intervention.
  • Arm: Celiac disease index cases
    Assessment of disease related factors, no intervention.

Primary Outcome Measure

Forthcoming celiac disease diagnosed by current diagnostic criteria [ Time Frame: With in 10 years ]

Find similar trials

Nationwide
Celiac disease trialsGastroenterology trialsAutoimmune disease trials

Related Studies